Clinical Trials Logo
  1. Home
  2. T2DM
  3. NCT03564431

The Imaging Genetic Study of Type 2 Diabetes and Depression

T2DM Clinical Trial

Official title:
The Study of Structural and Functional Brain Abnormalities and the Association With the Genetic Polymorphism in the Type 2 Diabetes Patient With Depression

Clinical Trial Summary

To investigate the structural/functional abnormalities and the possible genetic endophenotypes of in the Type 2 Diabetes Patient With Depression.

Clinical Trial Description

Diabetes and depression are harmful to human health,but they often co-exist.At present, the pathophysiological mechanisms underlying the comorbidity of diabetes and depression are discussed, including hypothalamic-pituitary-adrenal axis dysfunction, inflammation, epigenetics, disturbed circadian rhythms, environmental and behavioral factors,neuroimaging,etc.the purpose of the investigator's study is to investigate the structural/functional abnormalities and the possible genetic endophenotypes of in the Type 2 Diabetes Patient With Depression. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03564431
Study type Observational
Source Kunming Medical University
Contact Li Shi, MD
Phone 8687165324888
Email shili1026@163.com.cn
Status Recruiting
Phase
Start date December 1, 2017
Completion date December 1, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04544319 - Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg Phase 1
Recruiting NCT05996380 - A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes Phase 1
Recruiting NCT02037100 - Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children N/A
Recruiting NCT03563794 - Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes Phase 4
Completed NCT01990469 - Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin Phase 3
Active, not recruiting NCT05680129 - A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM Phase 3
Active, not recruiting NCT04609631 - Tai Chi for Comorbid Depression in T2DM Patients N/A
Completed NCT05681273 - Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects. Phase 1
Active, not recruiting NCT05680155 - A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients Phase 3
Recruiting NCT05159882 - Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM Phase 3